BRIEF published on 04/23/2026 at 14:05, 5 months 17 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Reverse Stock Split Immunic Inc. Stockholder Meeting Share Reduction Nasdaq IMUX
PRESS RELEASE published on 04/23/2026 at 14:00, 5 months 17 days ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split Immunic, Inc. announces a 1-for-10 reverse stock split to meet contractual obligations, reducing outstanding shares from 136M to 13.6M Shareholders Reverse Stock Split Nasdaq Immunic Inc. Neurologic Diseases
BRIEF published on 04/09/2026 at 12:35, 6 months 1 day ago Immunic participera à des conférences scientifiques majeures en avril Biotechnologie Conférences Essais Cliniques Thérapies Orales Neurologie
BRIEF published on 04/09/2026 at 12:35, 6 months 1 day ago Immunic to Engage in Key Scientific Conferences in April Biotechnology Clinical Trials Conférences Oral Therapies Neurology
PRESS RELEASE published on 04/09/2026 at 12:30, 6 months 1 day ago Immunic to Participate in Scientific and Medical Conferences in April Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF published on 04/01/2026 at 12:35, 6 months 9 days ago Immunic obtient la conformité au Nasdaq Biotechnologie Marché Boursier Immunitaire Conformité NASDAQ Thérapies Neurologiques
BRIEF published on 04/01/2026 at 12:35, 6 months 9 days ago Immunic Achieves Nasdaq Compliance Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
PRESS RELEASE published on 04/01/2026 at 12:30, 6 months 9 days ago Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases
BRIEF published on 03/31/2026 at 12:35, 6 months 10 days ago Immunic nomme Jon Congleton à son conseil d'administration Conseil D'administration Biopharmaceutique Sclérose En Plaques Immunitaire Jon Congleton
BRIEF published on 03/31/2026 at 12:35, 6 months 10 days ago Immunic Appoints Jon Congleton to Board of Directors Board Of Directors Biopharmaceutical Multiple Sclerosis Immunic Jon Congleton
Published on 10/10/2026 at 04:45, 12 hours 14 minutes ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 14 hours 56 minutes ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 14 hours 59 minutes ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 17 hours 59 minutes ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 18 hours 44 minutes ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 23 minutes ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 28 minutes ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 6 hours 53 minutes ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 19 hours 34 minutes ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 19 hours 41 minutes ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 21 hours 31 minutes ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 21 hours 31 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 23 hours 14 minutes ago Déclaration des droits de vote à fin septembre 2026
